Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP547732.RAEQdbDKGNjt6sjwdCjx2DTvyNF-Gf2KNEr1Dd_FkWLcA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP547732.RAEQdbDKGNjt6sjwdCjx2DTvyNF-Gf2KNEr1Dd_FkWLcA130_assertion type Assertion NP547732.RAEQdbDKGNjt6sjwdCjx2DTvyNF-Gf2KNEr1Dd_FkWLcA130_head.
- NP547732.RAEQdbDKGNjt6sjwdCjx2DTvyNF-Gf2KNEr1Dd_FkWLcA130_assertion description "[Finally, we show that MCF7 (breast cancer) and MOLT4 (T-cell acute lymphoblastic leukemia) cells having aberrant Notch1 signaling are chemoresistant, which can be reversed by both PI3K and mTOR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547732.RAEQdbDKGNjt6sjwdCjx2DTvyNF-Gf2KNEr1Dd_FkWLcA130_provenance.
- NP547732.RAEQdbDKGNjt6sjwdCjx2DTvyNF-Gf2KNEr1Dd_FkWLcA130_assertion evidence source_evidence_literature NP547732.RAEQdbDKGNjt6sjwdCjx2DTvyNF-Gf2KNEr1Dd_FkWLcA130_provenance.
- NP547732.RAEQdbDKGNjt6sjwdCjx2DTvyNF-Gf2KNEr1Dd_FkWLcA130_assertion SIO_000772 16651424 NP547732.RAEQdbDKGNjt6sjwdCjx2DTvyNF-Gf2KNEr1Dd_FkWLcA130_provenance.
- NP547732.RAEQdbDKGNjt6sjwdCjx2DTvyNF-Gf2KNEr1Dd_FkWLcA130_assertion wasDerivedFrom befree-2016 NP547732.RAEQdbDKGNjt6sjwdCjx2DTvyNF-Gf2KNEr1Dd_FkWLcA130_provenance.
- NP547732.RAEQdbDKGNjt6sjwdCjx2DTvyNF-Gf2KNEr1Dd_FkWLcA130_assertion wasGeneratedBy ECO_0000203 NP547732.RAEQdbDKGNjt6sjwdCjx2DTvyNF-Gf2KNEr1Dd_FkWLcA130_provenance.